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ABSTRACT 
 
The thesis entitled “Chiral 2,3-epoxy aldehydes as versatile electrophiles in 
Baylis-Hillman and Passerini reactions; Total synthesis of (2R,2′R)-threo-(+)-
Methylphenidate and α-pyrone containing natural product.” is divided into three 
chapters. 
 
Chapter-I: The chiral 2,3-epoxy aldehydes as versatile electrophiles in Baylis-
Hillman and Passerini reactions 
This chapter dealt with the chiral 2,3-epoxy aldehydes as versatile electrophiles in 
Baylis-Hillman and Passerini reactions and thorough study of their adducts. 
The chiral epoxy alcohols in turn are synthesized by Sharpless asymmetric 
epoxidation in their enentiomeric pure form. So, their easy preparation and immense 
usage in synthetic chemistry as attractive starting materials gained attention of most of 
the organic chemists. Oxidation of these chiral 2,3-epoxy alcohols under neutral 
conditions gives the enentiomerically pure 2,3-epoxy aldehydes without any 
racemization. These 2,3-epoxy aldehydes were used as wonderful electrophiles in C-C 
bond formation reactions.1 They are one of the chiral pool electrophiles, which can 
introduce the asymmetric induction in these reactions. This was proved by some of the 
precious work done by organic chemists on 2,3-epoxy aldehydes in several aspects. In 
this occasion we were also interested in exploring their immense usage in very famous C-
C bond formation reactions Baylis-Hillman reaction and Passerini reaction. We also 
studied the asymmetric induction of 2,3-epoxy aldehydes in their respective adducts. 
 
Section-A: Diastereoselective Baylis–Hillman reaction: First use of chiral 2,3-epoxy 
aldehydes as novel electrophiles. 
This section dealt with the first time introduction of 2,3-epoxy aldehydes in 
diastereoselective Baylis-Hillman reaction and adducts were studied. 
The Baylis–Hillman reaction is an important C–C bond forming reaction, which 
gives multifunctional products with complete atom economy.2 The introduction of novel 
electrophiles is important for the extension of the scope of the Baylis–Hillman reaction. 
Zwanenburg and co workers3 have reported the Baylis–Hillman coupling of N-trityl 
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aziridine-2-(S)-carboxaldehydes with activated alkenes to result in adducts, albeit with 
poor diastereoselectivity. Chiral 2,3-epoxy alcohols are versatile intermediates used in the 
enantio- and stereoselective total syntheses of natural products with polyfunctional 
groups.4 However, to the best of our knowledge, epoxy aldehydes have not been utilized 
as electrophiles in Baylis–Hillman reactions. Since chiral epoxides are important 
synthetic intermediates that can be easily generated with predictable stereochemistry 
from allyl alcohols by Sharpless asymmetric epoxidation5 and based on our interest in 
asymmetric Baylis– Hillman reactions,6 herein we introduce chiral 2,3-epoxy aldehydes 
(Scheme 1) for the first time as electrophiles in Baylis–Hillman reactions with alkenes to 
give densely functionalized adducts in good yields (61–80%) and in moderate to good 
diastereoselectivities (40–72% de). 
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CHO
O EWG
+ R O
OH
EWG
DABCO (0.5 eq)
DMF, rt
Scheme 1
 
 
The epoxy aldehydes used in the present study were prepared by adopting a 
general synthetic strategy (Scheme 2). The corresponding aldehyde (R = alkyl, aryl) was 
homologated under Wittig olefination condition to get corresponding α,β-unsaturated 
ester. We have performed the Wittig olefination in both polar (methanol) and non-polar 
solvents (benzene and CH2Cl2) to obtain both Z and E α,β-unsaturated esters. This α,β-
unsaturated ester was regiospecifically reduced with LiAlH4/AlCl3 (aluminum hydride or 
allene) to the respected allylic alcohol. Sharpless asymmetric epoxidation conditions 
were implied on allylic alcohol to get required epoxy alcohol in enentiomerically pure 
form. Finally, epoxy alcohol was oxidized to corresponding epoxy aldehyde under Swern 
oxidation conditions where neither racemization nor ring opening of oxirane has taken 
place.  
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a
Reagents and conditions: a) Ph3P=CHCOOEt, MeOH, 0 oC- rt / Benzene, reflux; b) LiAlH4 (1.5 
eq.), AlCl3 (0.5 eq.), ether, 0 oC- rt; c)  (+)-DIPT, Ti(OiPr)4, cumene hydroperoxide, CH2Cl2, 4Ao MS, 
-20 oC; d) (COCl)2, DMSO, Et3N, CH2Cl2, -78 oC.
 
 Subsequently, the first Baylis–Hillman coupling of an epoxy aldehyde 1 was tried 
with ethyl acrylate a in THF, dioxane–H2O7 (1:1) and DMF catalyzed by DABCO (0.5 
eq.) at room temperature. Among all the solvents tried, DMF proved to be the appropriate 
solvent with a faster reaction rate. 
The syn:anti ratio of the adducts was determined by 1H NMR and HPLC (Chiral 
OD column) analysis. The 1H NMR spectra of similar products revealed the allylic 
protons for the syn isomers resonating up field compared with their anti counterparts.8 
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R =
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(a) X  = COOEt
(b) X = CN
, DABCO
DMF, rt, 3-8 h
MPMO
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1
2
3
4
1a X = COOEt (62%, syn:anti, 27:73)
2b X = CN (67%, syn:anti, 30:70)
3a X = COOEt (73%, syn:anti, 26:74)
3b X = CN (76%, syn:anti, 29:71)
4a X = COOEt (61%, syn:anti, 30:70)
4b X = CN (64%, syn:anti, 25:75)
Scheme  3
 
 
For instance, the major isomer in 4a was assigned as anti because of the 
downfield resonance of the allylic proton at δ 4.58 while the same proton resonated at δ 
4.39 for the minor isomer (scheme 3). Also, 4a had the olefinic protons resonating at δ 
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6.36 and 6.01 for the major isomer, while the same protons resonated at δ 6.32 and 5.94 
for the minor isomer with a 7:3 integral ratio. Likewise, the 1H NMR spectrum of 4b 
demonstrated one of the olefinic protons resonating at δ 6.24 for the major isomer and at 
δ 6.09 for the minor isomer with an integral ratio of 7.5:2.5. The allylic proton resonated 
at d 4.50–4.43 as a multiplet for the major isomer, integrating for 0.75H, while the signal 
of the corresponding proton merged with the –OCH2 signal for the minor isomer. 
Similarly, in the 1H NMR spectrum of 5a the olefinic protons resonated at δ 6.30 
and δ 5.91 for the minor isomer, while the comparable protons appeared at δ 6.27and d 
5.81 for the major isomer (Scheme 4). Also, the allylic proton for the major isomer 
resonated at δ 4.01 while the signals for the comparable proton of the minor isomer 
merged with the ester –CH2 protons. 
                
R O
X
(a) X = COOEt
(b) X = CN
, DABCO
DMF, rt, 3-8 h
R X
HO H
R
+
X
H OH
R =
OBn
O
O
BnO
5
6
7
syn (major) anti (minor)
5a X = COOEt (75%, syn:anti, 83:17)
5b X = CN (80%, syn:anti, 75:25)
6a X = COOEt (63%, syn:anti, 78:22)
6b X = CN (65%, syn:anti, 81:19)
7a X = COOEt (74%, syn:anti, 76:24)
7b X = CN (78%, syn:anti, 86:14)
O OO
Scheme 4
 
 
Thus the trans epoxy aldehydes (1-4, scheme 3) on Baylis–Hillman reaction with 
alkenes a and b under the standardized reaction conditions (DABCO, DMF, rt) afforded 
the anti-isomers as major products (1a, 2b, 3a, b and 4a, b) while cis epoxy aldehydes 
(5–7, Scheme 4) afforded the syn-isomers as major products (5a, b, 6a, b and 7a, b). The 
observed selectivity could be explained by the Cornforth model9 wherein nucleophilic 
attack occurs from the least hindered side (Fig. 1). 
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Figure 1 Cornforth Model
 
 
  For instance, in the case of cis epoxy aldehydes, the Re face is more available for 
nucleophilic attack leading to syn adducts as major isomers, while for trans epoxy 
aldehydes the Si face is more open for nucleophilic attack ensuring anti-adducts as major 
products. Incidentally, the de of adducts originating from cis epoxy aldehydes was more 
than that of the adducts from trans epoxy aldehydes primarily due to the steric crowding 
of substituents on either side of the epoxide ring. 
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(+)-DIPT
 
Chemical correlation method 
Additionally, a chemical correlation was undertaken (Scheme 5) to determine the 
stereochemistry of the newly created centre of the adducts. Accordingly, allyl aldehyde 8 
on Baylis–Hillman reaction (DABCO/DMF/rt) with acrylonitrile (b) afforded adduct 9 
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(55%), which on Sharpless asymmetric epoxidation with (+)-DIPT resulted in 
enantiopure (S)-4b anti (39%) and (S)-9 (35%). Further, (S)-9 on Sharpless asymmetric 
epoxidation with (+)-DIPT gave enantiopure (R)-4b syn (72%). Both these products were 
used as standard samples for comparison with 4b obtained earlier as an syn:anti mixture 
(Scheme 3). The 1H NMR spectrum of S-4b showed the allylic proton resonance at δ 
4.46, a doublet with J = 16.6 Hz (anti-isomer) while the same proton for R-4b resonated 
at δ 4.13 as a doublet with J = 4.5 Hz (syn-isomer). Likewise, the HPLC of the 
enantiopure (S)-4b anti- and (R)-4b syn-adducts independently, upon correlation with the 
earlier sample (4b, Scheme 3) proved unequivocally that the major isomeric adduct was 
anti. Similarly, HPLC of enantiopure syn-4b (Scheme 5) matched with the minor isomer 
of 4b (Scheme 3).  
In conclusion, we have demonstrated for the first time the use of chiral 2,3-epoxy 
aldehydes in Baylis–Hillman reactions to generate chiral epoxy alcohols with an α-
methylene group, in good yields and selectivity. The Cornforth model clearly suggests 
that the cis epoxides give syn-adducts as major compounds while the trans epoxides 
resulted in anti-adducts as major products under standard base-catalyzed conditions. 
Interestingly, this protocol can also be extrapolated to the other isomeric epoxy 
aldehydes. Thus, chemically more sensitive substrates can be useful as electrophiles in 
the Baylis –Hillman reaction. Further work on the use of these adducts is in progress. 
Note: Published in Tetrahedron Letters, 2004, 45, 7847-7850. 
 
Section-B: Diastereoselective Passerini Reaction of Chiral 2,3-Epoxy Aldehydes with 
TosMIC. 
This section dealt with the Diastereoselective Passerini Reaction of Chiral 2,3-Epoxy 
aldehydes with TosMIC (Tosylmethyl Isocynide). 
Passerini, Ugi and others have recognized the unique synthetic utility of isonitriles 
to serve as a latent amide function,10 which found significant applications in heterocyclic 
ring synthesis and drug discovery.11 Asymmetric Passerini reaction has gained 
prominence in recent times.12 Notable is the extensive use of amino aldehydes derived 
from natural amino acids towards a diastereoselective Passerini reaction.13 Chiral 
catalyst-assisted14 enantioselective Passerini coupling reactions and the use of chiral 
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acids15 for achieving high stereoselectivities are noteworthy. Earlier, Passerini reaction 
using achiral epoxy aldehyde was reported by Armstrong et. al.16 however, 
stereochemical inductions were not assessed. Hence, a thorough study was undertaken to 
understand the stereocontrol of chiral 2,3-epoxy aldehydes during Passerini reaction.  
We have realized that a Passerini reaction of TosMIC and chiral 2,3-epoxy 
aldeyhdes manifests into products endowed with diverse functionalities and an additional 
methylene group to serve as a handle for further manipulation. These were the results on 
the first use of TosMIC and chiral 2,3- epoxy aldehydes in Passerini coupling reaction 
(Scheme 1). 
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R CHO
PhCOOH CH2Cl2
O
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H
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O
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+ TosMIC +
rt, 48 h
1-9 1a-9a
Scheme 1
 
All the chiral 2,3-epoxy aldehydes were synthesized by adopting the known 
procedure (discussed in section 1) for use as starting materials in the Passerini reaction. 
Initially, the three-component Passerini reaction (P-3CR) of cis-2,3-epoxy aldehyde 1 in 
presence of TosMIC and benzoic acid in different solvents was tried at room temperature 
(Table 1). The optimum yield of the product 1a (79%) was obtained when aldehyde 1, 
benzoic acid and TosMIC were reacted in dichloromethane at room temperature. Hence, 
CH2Cl2 was elected as the solvent for all further reactions. In a parallel study, Lewis acid 
mediated Passerini reactions were also analyzed. However, no product was observed 
when ZrCl4/TMSCl or Sc(OTf)3/TMSCl were used. This could be attributed to the 
instability of 2,3-epoxy aldehydes in presence of Lewis acids.  
                                 
SNo
MeOH
DMSO
THF
CH2Cl2
Aldehyde Solvent Product(%)
Table 1 Passerini reaction of 1 with PhCOOH, 
TosMIC under different solvents
1. 1 1a(15)
2. 1 1a(38)
3. 1 1a(42)
4. 1 1a(79)
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Subsequently, Passerini reaction of other epoxy aldehydes 1–9 under standardized 
reaction conditions afforded products 1a–9a as inseparable mixtures in moderate to good 
yields (50–75%) and in moderate to good de (40–70%, Table 2). It is observed that the 
trans-epoxy aldehydes (2, 3, 5 and 7) afforded syn-isomers as major products (Table 2) 
and correspondingly the cis-epoxy aldehydes (1, 4, 6, 8 and 9) afforded anti-isomers as 
major products (Table 2). 
The syn:anti ratio of the products was determined by 1H NMR spectra, recorded 
in CDCl3, wherein the relative integration of separable protons were compared. The 1H 
NMR spectra of similar products revealed the α-proton for the syn-isomers resonating 
more downfield than their anti-counterparts.17 For instance, the major isomer in 3a was 
assigned as syn because of the downfield resonance of the α proton at δ 5.42 (J = 3.50 
Hz) while the same proton resonated at δ 5.24 (J = 5.20 Hz) for the minor isomer with an 
integral ratio of 8.5:1.5. Aromatic protons as well the epoxy protons of 3a also exhibited 
same integral ratio favoring the anti-isomer.  
Likewise, the major isomer in 4a was assigned as anti because 1H NMR displayed 
the α-proton at δ 5.14 (J = 9.44 Hz) while the same proton resonated at δ 5.16 (J = 7.55 
Hz) for the minor isomer with an integral ratio of 8.3:1.7. Similarly, all the products 1a, 
2a, 5a–9a were characterized by their spectral data and their diastereomeric excess was 
calculated from 1H NMR spectra (Table 2). 
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Entry Aldeyhde Productb Yieldc
3a 50%
2
3
4 4a
2a
1a
64%
57%
79%
6
5a
8a
52%
58%
Table 2. Three component Passerini reaction  (P-3CR) between  chiral 2,3-epoxy 
aldehyde, TosMIC and PhCOOH
64%
75%
ded(%)
1
5
7
8
6a
7a
70 (syn:anti, 85:15)
66 (syn:anti, 17:83)
60 (syn:anti, 80:20)
40 (syn:anti, 30:70)
50 (syn:anti, 75:25)
46 (syn:anti, 27:73)
46 (syn:anti, 68:32)
40 (syn:anti, 30:70)
3
4
2
1
5
6
7
8
9a 75% 44 (syn:anti, 23:77)
9
9
a ) All the reactions were conducted as described in the general experimental 
procedure in the reference section.
b)  All the products were thoroughly characterized by their spectral data.
c)  Isolated yields are mentioned as the combined yield of two isomers.
d)  The de values are calculated from their 1H NMR spectra.
 
 
Reason for diastereoselectivity 
Stereochemical outcome maybe be explained invoking the well-established 
mechanism cited for the classical Passerini reaction,18 Which involves the reaction of the 
isonitrile with loosely bound adducts A and B (Figure 1), initially formed by the reaction 
of the carboxylic acid with the carbonyl compound.  
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Figure 1:  Transition state models
R1 = Alkyl substituent
R2 = Ph
= Transition state interactions
= H-bonding interactions
Nu Nu
 
These adducts might also be seen as tight ion pairs resulting from protonation of 
carbonyl by the carboxylic acid. Consequent to their formation, the isomeric bias may be 
explained by the following transition state models as depicted in Figure 2.19 There is 
diastereofacial preference for the entering isonitrile from the less hindered side for both 
the acid chelated cis and trans epoxy aldehydes, i.e. from the Re face to ensure a syn 
product (major) for the trans epoxy aldehyde and from Si face to afford an anti-product 
(major) for the cis-epoxy aldehyde.  
Double Asymmetric Induction 
Passerini reaction of 1 in presence of TosMIC and other organic acids was also 
studied in CH2Cl2 (Table 3). While in TFA no product was formed, in acetic acid 1b was 
obtained in 15 % yield.  
                     
NBoc
O
COOH
N
Boc
COOH
NBoc
O
COOH
N
Boc
COOH
Entry Aldehyde Acid Product
1 1 TFA
2 1 AcOH 1b 15%
3 1 1c 67% (44% de)
5 1 1d 69% (43% de)
Table 3. Study of different organic acids in Passerini reaction
10
11
 4 9 9b  64% (86% de)
10
6 9 9c 67% (80% de)
11
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Later, the concept of ‘double asymmetric induction20 was checked in Passerini 
reaction in the presence of chiral acids. Accordingly, cis 2,3-epoxy aldehyde 1 in the 
presence of chiral acid 10 and TosMIC gave 1c in 67% yield (44% de) and the same 
aldehyde in the presence of N-Boc-L-proline 11 gave 1d in 69% yield (43% de, Table 3). 
Further, in order to evaluate the match/mismatch effects, when the epoxy aldehyde 9 (an 
enantiomer of 1) was subjected to Passerini reaction in the presence of chiral acids 10 and 
11 under similar reaction conditions 9b and 9c respectively, were obtained in comparable 
yields but with enhanced selectivities (86% and 80% de, respectively). 
The steric crowding is more pronounced when the acid component is a chiral 
entity resulting in enhanced diastereoselectivity (9b and 9c, ca. 80% de) in a matched 
pair and less selective due to low steric bias for the isonitrile addition in a mismatched 
case (1c and 1d, ca. 40% de).20 
In conclusion, we have demonstrated a diastereoselective three-component 
Passerini reaction (P-3CR) using sensitive chiral 2,3-epoxy aldehydes with TosMIC to 
generate densely substituted products12,13 in moderate to good yields and de. It was 
observed that trans-epoxy aldehydes gave syn-isomers as major products while the cis-
epoxy aldehydes gave anti-isomers as major products. In the case of aldehydes 3 and 4, 
the steric crowding posed by the acetonide group adjacent to the epoxide ring enhanced 
the stereoselectivities. ‘Double asymmetric induction’ in Passerini reaction was also 
performed to improve the selectivities. It is pertinent to mention that this methodology 
can equally be extrapolated to other isomeric epoxy aldehydes as well. 
Note: Published in Synlett. 2007, 83-86. 
 
Chapter-II: A concise stereoselective total synthesis of (2R,2'R)-threo-(+)- 
Methylphenidate via RCM protocol. 
This Chapter dealt with the stereoselective total synthesis of the (2R,2'R)-threo-(+)- 
Methylphenidate  by using Ring Closing Metathesis protocol. 
(±)-threo-Methylphenidate hydrochloride commonly called Ritalin on the market, 
is used mainly for the treatment of attention deficit hyperactivity disorder (ADHD) in 
children in the USA.21 This medication is also used to treat patients with Narcolepsy (or 
disorder of sleep regulation). Methylphenidate is a mild stimulant that works by affecting 
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the levels of neurotransmitters in the nervous system. It has been marketed as racemate 
although the (2R,2'R)-threo-methylphenidate hydrochloride (1; figure 1) is ca. 13 times 
more active than the corresponding (2S,2'S)-threo-(-)-methylphenidate hydrochloride 
(ent-1).22  
                  
H.HCl
N
CO2CH3
H.HCl
N
CO2CH3
(ent-1) (2S,2'S)-threo-methylphenidate
                  hydrochloride
22'
2
2'
(1) (2R,2'R)-threo-methylphenidate 
                  hydrochloride
Figure 1
 
Various synthetic approaches for the preparation of the active isomer have been 
reported including resolution,23 catalyst mediated24 and few stereoselective syntheses.25 
Amongst the reported syntheses, the enantioselective synthesis by Winkler et al24 using 
Doyle’s rhodium catalyzed C-H insertion reaction based synthetic route is the shortest. A 
recent review encompassing all the previous syntheses is worth noting. Recently we have 
introduced chiral 2,3-epoxy aldehydes as electrophiles in diastereoselective Baylis-
Hillman reaction26 and in Passerini reaction.27 In continuation of our interest in the use of 
chiral epoxides, herein we have invoked Sharpless asymmetric epoxidation for generating 
two contiguous stereocenters and Grubbs’ ring-closing metathesis protocol as the key 
steps towards the total synthesis of methylphenidate 1 (Scheme 1).  
 
                        
H.HCl
N
COOMe
Ph
OH
O
NH Ph
O
OTBDPS
OH
Scheme 1:  retrosynthetic path
1 2
3 4
2' 2
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Accordingly, chiral piperidine present in 1 was built through the ring-closing 
metathesis of bis-olefin 2. The amino functional group was introduced by SN2 mode of 
the diol which in turn was obtained by the regioselective ring-opening reaction of 
epoxide 3 by Ph2CuLi. The appropriate stereoselective epoxide 3 was efficiently prepared 
from Sharpless asymmetric epoxidation of allylic alcohol obtained by the selective 
reduction of allylated propargyl alcohol, which in turn could be prepared from the 
commercially available propargyl alcohol (4). 
Thus, propargylic alcohol (4; Scheme 2) upon coupling with allyl bromide in 
presence of CuI-K2CO3-TBAI in DMF at room temperature, gave 5 in 85% yield.28 The 
triple bond present in 5 was partially reduced in presence of Nickel acetate and catalytic 
amount of sodium borohydrate to afford 6 (90%).29 
                
OH OH OH
OH
O
OH
HO Ph
OH
Ph OH+
Scheme 2
4 5 6
7a 7b
b ca
d
3
Reagents and conditions: (a) allyl bromide, CuI, TBAI, K2CO3, DMF, rt, 85%; (b) 
Ni(OAc)2.4H2O, Ethylenediamine, NaBH4, H2 atm, EtOH, rt, 90%; (c) Ti(OiPr)4, (-) 
DIPT, Cumene hydroperoxide, CH2Cl2,  -20 
oC, 83%; (d) (i) PhLi, CuI, ether , -40 oC 
to 0 oC, (ii) NaIO4, MeOH, 73% over two steps.
 
 
Later, 6 on Sharpless asymmetric epoxidation with cumene hydroperoxide in 
presence of (-)-diisopropyl D-tartrate and titanium(IV) isopropoxide afforded 3 (83%).30 
The enentiomeric excess of epoxide 3 was calculated to be 92% by correlating with the 
literature values.31 Later chelation-assisted regioselective nucleophilic ring-opening 
reaction 32of epoxide 3 with PhLi in presence of CuI gave the requisite 1,3 diol 7a (73%) 
as the major product, while the minor product 1,2 diol 7b (8%; 7a/7b = 9:1) was removed 
by oxidative cleavage (NaIO4-MeOH-r.t.).                                                   
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PCy3
Cl
Cl
Scheme  3
Ru
Grubbs' Ist generation catalyst (I)
Reagents and conditions: (a) TBDPSCl, Imidazole, CH2Cl2,  rt,  95%; (b) MsCl, Et3N, 
CH2Cl2, 0 
oC to rt, 87%; (c) NaN3, DMF, 80 oC, 73%; (d) TPP, MeOH,  rt; (e) Acryloyl 
chloride, Et3N,  CH2Cl2, 0 
oC to rt, 62 % over two steps; (f)  Grubbs catalyst I  (15 mol%), 
CH2Cl2,  reflux, 75%.
a
7a
8 9
210 11
b
d, e
c
f
 
The diol 7a (Scheme 3) was selectively protected as its TPS ether 8 with TBDPS 
chloride and the secondary alcohol was comfortably transformed into amine by three step 
process. Firstly, the secondary alcohol was mesylated (MsCl-Et3N-CH2Cl2, rt), which 
was then converted into the corresponding azide (NaN3-DMF, 80 oC) via SN2 pathway. 
Later, azide 10 was reduced to amine under Staudinger reaction conditions.33 Initially, a 
more prudent stretagy for constructing the azacyclic part of the molecule was conceived 
through the reduction of the azide functionality to amine, its conversion into Boc 
cabamate (Boc2O-Et3N-THF, rt), allylation of the carbamate as allyl amide (allyl 
bromide-NaH-DMF or THF) following by the ring closing metathesis reaction. However, 
it was observed that the highly acidic benzylic proton was easily deprotonated under 
several allylation reaction conditions resulting in a recemic allylated product. The crude 
amine thus obtained was acrylated (acryloyl chloride-Et3N-DMAP-CH2Cl2, rt) to afford 
bisolefin 2 in 62% yield. Ring-closing reaction of 2 was effected using Grubbs’ first-
generation catalyst (I; 15 mol%) in CH2Cl2 at reflux temperature to give lactam 11 
(75%).34 
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OTBDPS
Ph
NH
O
OTBDPS
Ph
NH
OTBDPS
Ph
NBoc
OH
Ph
NBoc
COOH
Ph
NBoc
ref . 5b
12 13
b
Reagents and conditions: (a) Pd/C, H2 atm, rt, 86%; (b) (i) BH3.DMS, THF,  0 oC to rt; (ii) EtOH,  
reflux, 82%; (c)  (Boc)2O, Et3N, THF, 0 oC to rt, 85%;  (d)  HF:Py, THF,  rt, 80%; (e) Dess-Martin 
periodnane, CH2Cl2,  0 
oC;  (f) NaClO2, NaH2PO4.2H2O, tBuOH:2-Methy-2-butene  (2:1), 0 oC-rt, 
12 h, 89% over two steps.
a
14
15 16
1
c
e, fd
11
Scheme 4
 
Next, in order to transform the α,β-unsaturated lactam into piperidine ring, we 
tried to reduce both olefin and amide functionalities in a single step with LAH but 
observed that the racemization was more facile, and no 1,2- or 1,4-addition products were 
observed.  Hence it was decided to opt for a mild and stepwise reduction of α,β-
unsaturated lactam ring. Consequently, first the olefin functionality was saturated in 
presence of Pd/C in H2 temperature at room temperature and later the amide functionality 
was efficiently reduced with BH3.DMS in presence of EtOH35 to result in the requisite 
amine 13 in very good yields (82%). 
Next, amine (13; Scheme 4) was protected as its carbamate 14 {85%; Boc2O-
Et3N-THF-rt) and the silyl group was deprotected with HF:Py at room temperature 
without any racemization to produce the alcohol 15 (80%).25b The required acid 16 was 
obtained in two consecutive steps, firstly the alcohol was oxidized to aldehyde in 
presence of Dess-Martin periodonane36 under basic conditions. The crude aldehyde thus 
obtained was oxidized to acid 16 (89% over two steps) under sodium chlorite oxidation 
(NaClO2-NaH2PO4.2H2O-tBuOH:2-methyl-2-butene) conditions. Treatment of the acid 
16 with methanolic HCl at 50 °C yielded the desired (2R,2'R)- threo-(+)-methylphenidate 
hydrochloride (1) in 70% yield. All the spectral and analytical data of 1 were identical to 
those of reported  previously.23 
In conclusion, we described a concise total synthesis of (2R,2'R)-threo-(+)-
methylphenidate hydrochloride (1), the active isomer of Ritalin in high optical purity. 
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Herein, we have used Sharpless asymmetric epoxidation for the generation of two 
contiguous stereocenters and Grubb’s ring closing metathesis as the key step to construct 
the piperidine ring. The strategy reported herein is suitable for synthesizing all possible 
isomers of methylphenidate in enentiomeric pure form of analogues thereof. The present 
synthesis avoids the use of chiral auxiliary or resolution, thus making it more adoptable.   
Note: Published in Synlett. 2007, 1742-1744. 
 
Chapter-III: Syntheses of 5,6-dihydro pyron-2-one (α-pyrone) containing natural 
product. 
The chemistry of natural products attracts a very lively interest. New substances, 
more or less complicated, more or less useful are constantly discovered and their 
properties investigated. Lactone rings are a structural feature of many natural products.37 
Of the naturally occurring lactones, which all display a wide range of pharmacological 
activities,38 those bearing a 5,6-dihydropyran-2-one moiety are relatively common in 
various types of natural sources.39 Because of their manifold biological properties, these 
compounds are of marked interest not only from a chemical, but also from a 
pharmacological perspective. As a matter of fact, 5,6-dihydropyran-2-ones of both 
natural and non-natural origin have been found to be cytotoxic.40 In addition, they inhibit 
HIV protease,41 induce apoptosis,42,43 and have even proven to be antileukemic,44 along 
with having many other relevant pharmacological properties.45 At least some of these 
pharmacological effects may be related to the presence of the conjugated double bond, 
which acts as a Michael acceptor.37a,46 
Over the past two decades, an increasing number of α-pyrones have been isolated 
from a variety of sources. Some of important biologically active pyrones are listed in 
Figure 1. McLaughlin et. al.47 reported the isolation of Goniopypyrone  (1) and 8-acetyl-
goniotriol (2) from Goniothalamus giganteus, both of these compounds are cytotoxic to 
human tumor cells. Argentilactone48 (3) was first isolated in 1977 from the rhizomes of 
Aristolochia argenita, and exhibit both antileishmanial activity and cytotoxic activity 
against mouse leukemia cells. 
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From syncolostemon rotundifolius, Davies-Coleman and Rivett49 reported the 
compound Syntrotolide (4). Boronolide50 (5) occurs in the leaves of Tetradinia barberae, 
whose stereochemistry was confirmed by Davies-Coleman and Rivett. Passifloricin A51, 
inhibits the cell cycle progression in M-phase, (-)-Pironetin52 (6) exhibits 
immunosuppressive activity and cytotoxic activity exhibited by Callystatin A53 (9) and 
Leptomycin B54 (10). Fostriecin55 (8) is under clinical evaluation as an antitumor drug in 
clinical trials, it inhibits the DNA, RNA and protein synthesis and was shown to block 
cells in the G2 phase of the cell cycle and to have inhibitiory effects on partially purified 
type II topoisomerase from Ehrlich Ascites carcinoma. 
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Section-A: A short stereselective synthesis of (+)-(6R,2′S)-Cryptocaryalactone via 
ring-closing metathesis.  
This section dealt with the short stereselective synthesis of (+)-(6R,2′S)-
cryptocaryalactone via ring-closing metathesis. 
Natural products play an important role in the development of drugs and mankind 
has always taken advantage of nature as pharmacy: approximately 40% of the drugs that 
have been approved over the last years are either natural products or derivatives and 
analogs thereof.56 As a matter of fact, 5,6-dihydropyran-2-ones of both natural and non-
natural origin have been found to be cytotoxic. In addition, they inhibit HIV protease,5 
induce apoptosis,42,43 and have even proven to be antileukemic,44 along with having many 
other relevant pharmacological properties.45 At least some of these pharmacological 
effects may be related to the presence of the conjugated double bond, which acts as a 
Michael acceptor.37a,46  
One of the sub-class of these 5,6-dihydro-2Hpyran-2-one compounds is styryl 
lactones which processes styryl moiety as side chain. Where as styryl moiety of the 
Goniothalamin plays leading role in having cytotoxic effect on different cancer cells, 
antimicrobial, larvicidal activity and anti-inflammatory activity.57 Indeed, the styryl-
pyrone skeleton is most important in a number of primitive Angiosperm families, such as 
Laurenceae, Piperaceae, Ranunculaceae, Zingiberaceae and Eqisetacease. 
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O
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Cryptocaryalactone (1),58 Kurzilactone (2), Goniothalamin (3)59, (+)-Cryptofoline 
(5)60 and (+)-Obolactone (4)61 (Figure 1) are some of the naturally occurring styryl 
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lactones. (+)-(6R,2′S)-cryptocaryalactone (1) first featured in the phytochemical literature 
when its isolation from Cryptocrya bourdilloni GAMB (Lauracene) was reported in 1972 
by Govindachari.62 It’s absolute stereochemistry was established by H. M. Meyer through 
stereoselective synthesis.63a All other possible isomers of Cryptocarya lactone were also 
isolated from C. bourdilloni, C. Moschata and C. myrtifolia and their absolute 
configuration was established.64 These cryptocaryalactones are natural germination 
inhibitors without affecting corn.65 As we were interested in synthesizing natural products 
containing 5,6-dihydro-2Hpyran-2-one moiety, here in a short and efficient synthesis of 
cryptocaryalactone 1 is described. 
  
O OAc
O
O OAc
O
OPMBOH
OH
O
Ring closing metathesis
Figure 2: Retrosynthetic approach
2'
6 2'
6
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2'
6
1 6
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The retrosynthetic strategy (Figure 2) reveals that compound 1 could be 
synthesized from corresponding bis-olefin 6 by ring-closing metathesis, which was 
obtained from acryoylation of homolallylic alcohol which inturn synthesized from 7. 
Chiral propargyl alcohol 7 was constructed from corresponding aldehyde by Carreira 
asymmetric alkynylation where in this aldehyde was synthesized from the corresponding 
primary alcohol which inturn was obtained from regioselective ring opening of 2,3-epoxy 
alcohol 8. 
The known 2,3-epoxy alcohol 8 was synthesized from corresponding allylic 
alcohol by well established Sharpless asymmetric epoxidation conditions and epoxy 
alcohol 8 was obtained in >94% ee as shown in literature.31 
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Reagents and conditions: (a)  (i)  Red-Al, THF, 0 oC; (ii)  NaIO4, CH2Cl2, sat.Na2CO3(cat.), 88% 
 over two steps; (b) anis aldhyde dimethyacetal, cat.PTSA, THF, 95%;  (c) DiBAL-H, CH2Cl2, 0 
oC, 92%;  (d) (i) (COCl)2, DMSO, Et3N, CH2Cl2, -78 oC, 98%;  (ii)  phenyl acetylene, Et3N, 
Zn(OTf)2, (-)-N-Methylephedrine, 25 oC, 78%  (>95%  de).
 
Compound 8 on reductive ring-opening reaction with Red-Al under standard 
condition furnished the 1,3-diol 9 in 88% yield. The traces of 1,2-diol was reductively 
cleaved with NaIO4 in presence of catalytic amount of saturated NaHCO3 solution. Thus 
obtained diol 9 was protected with anisaldehyde dimethylacetal in presence of PTSA to 
afford compound 10 95% yield which was regioselectively opened with DIBAL-
H/CH2Cl2/0 oC to give primary alcohol 11 in 92 % yield.  
The primary alcohol 11 was oxidized under Swern conditions 
{(COCl)2/DMSO/Et3N/CH2Cl2/-78 oC} and the crude aldehyde was exposed to 
alkynylation reaction directly. Several base mediated alkynylation conditions were 
examined to get the requisite propargyl alcohol (Table 1). 
        
Reagents de's
n-BuLi
LDA
LDA/HMPA
28%
56%
78%
>94%
Table 1: Asymmetric alkynylation with phenyl acetylene
Solvent Temperature
THF
THF
THF
Toluene
-78 oC
-78 oC
-78 oC
25 oCZn(OTf)2, Et3N,(-) N-methylephedrine
 
Among all, Carreira asymmetric alkynylation gave excellent diastereomeric 
excess. Thus the well stabilized conditions (Zn(OTf)2/Et3N/(-)-N-Methyl 
ephedrine/phenyl acetylene)66 were employed on aldehyde to obtain propargyl alcohol 7 
with require configuration (>94% de). The compound 10 was confirmed with 1H NMR 
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spectrum and 13C spectrum (Scheme 2). The absolute stereochemistry was assigned based 
on the Ryschnovsky’s analogy.67 
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a
13C NMR of acetonide carbons  = 23.6, 28.8 and 100.3 ppm
b
Reagents and conditions: (a) CAN, CH3CN:H2O (1:1), rt, 84%; (b) 2,2-DMP, cat.PTSA, rt, 92%.
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According to the literature secondary 1,3-diol configuration could be predicted 
through the chemical shift of acetonide carbon atoms in 13C NMR spectrum. So, upon 
deprotection of the compound 7 under Lewis acid conditions {CAN/CH3CN:H2O (1:1)} 
gave diol 12 (84%) which on further protection with 2,2-DMP in presence of catalytic 
amount of PTSA furnished compound 13. The analytical data of acetonide 13 has 
confirmed the configuration of 1,3-diol as anti. Since the first hydroxyl center was 
obtained through unambiguous method, the newly created hydroxyl functionality could 
be confirmed as the one depicted in Scheme 2. 
             
Scheme 3
7
14 15
1
a b
Reagents and conditions:  (a)  LiAlH4, THF, 0 oC, 87%; (b) Ac2O, Et3N, DMAP, CH2Cl2, 
0 oC to rt, 92%; (c) DDQ, CH2Cl2:H2O (19:1), 89%;  (d) Acryloyl chloride, DIPEA, DMAP, 
CH2Cl2, 82%;  (e) Grubbs' 1st generation catalyst (10 mol%), CH2Cl2,  reflux, 8h, 58% .
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BMPO OH
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c d
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The propargylic alcohol 7 was chemoselectivily reduced with LiAlH4 in THF at 0 
oC temperature to obtain cinnamyl alcohol 14 (87%). Alcohol 14 was protected with 
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acetate group under globalize reaction conditions. Methoxy benzyl group in compound 
15 was selectively deprotected to afford homoallylic alcohol 16 (89%) under 
DDQ/CH2Cl2/H2O (19:1) conditions without the migration of acetyl group. Compound 
16 was acrylated under acryloyl chloride/Et3N/CH2Cl2/0 oC to furnish the required bis-
olefin 6 in 82% yield. Ring-closing metathesis of bis-olefin 6 with Grubbs’ 1st generation 
catalyst (10 mol%)34 gave the required (+)-(6R,2′S)-cryptocarya lactone (1) as solid in 58 
% of yield {m.p. 122-125/lit. 126-127 and [α]D= +21.4 (c = 0.025)/lit.= +19.0 (c = 
0.67)}.63a All the spectral data was matched with the literature values. 
 
Section-B: Studies towards the total synthesis of (5R,7S)-Kurzilactone. 
This section dealt with studies towards the total synthesis of (5R,7S)-Kurzilactone.                
Kurzilactone was isolated from leaves of Cryptocarya kurzii, a plant which is 
indigenous to Malaysia.68 It is a new Kawa-type lactone where they bear close structural 
relationship to the pharmacologically important statin family which are highly potent 
inhibitors of 3-hydroxy-3-methylglutaryl agent coenzyme A reductase.69 Kurzilactone 
shows remarkable cytotoxicity against KB cells (IC50 = 1 µg/ mL).68a Previously Biao 
Jiang et. al. synthesized and proposed the absolute stereochemistry of (5R,7S)-
Kurzilactone and its diastereomer starting through BINAP mediated reduction.70  Jinsung 
Tae et. al. had attempted synthesis of (5S,7R)-Kurzilactone by using HKR method.71  
Our interest in synthesis of biologically active molecules resulted in Cryptocarya 
diacetate, Decarystictin D and related natural products.72 Commonly 1,3-diol subunits are 
present in numerous biologically active natural products and pharmaceuticals. As a result, 
a large effort has been devoted to the development of methods for the stereoselective 
synthesis of 1,3-diols. Several methods were developed including Jacobson’s hydrolytic 
kinetic resolution (HKR) and most facile way is to use 1,3-induced selective reduction of 
carbonyl has appropriate boron reagents.73 Here we have proposed selective reduction of 
β-hydroxy ketone with tetramethylammonium triacetoxyborohydride (Me4NBH(OAc)3). 
Later the 5,6-dihydro-pyrone ring was constructed from corresponding cis α,β-
unsaturated ester. The most important cinnamate part was constructed from oxidation of 
alcohol obtained by coupling with phenyl acetylene.   
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The retrosynthetic route showed that Kurzilactone (1; Figure 1) was obtained 
from ester 2 by deprotection to get diol first which and simultaneously cyclized under 
acidic medium and then acetate deprotection and oxidation. Compound 2 was envisaged 
from coupling between aldehyde of the fragments 3 obtained by ozonolysis and 
penylacetylene under basic conditions. The chiral fragment 3 was obtained by acetonide 
protection of corresponding diol synthesized by 1, 3 selective induced reduction of 
ketone 5. The ketone 5 was obtained by oxidation of corresponding alcohol synthesized 
from allylation of the aldehyde obtained from epoxide 6 by Red-Al opening and selective 
protection of secondary alcohol and then oxidation of primary alcohol.  
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Reagents and conditions: (a) Red-Al, THF, rt, 92%; (b) BzCl, Et3N, cat.DMAP, CH2Cl2, 0 oC, 86%; (c) 
TBDMSCl, Imidazole, CH2Cl2, rt, 90%; (d) K2CO3, MeOH, rt, 89%; (e) (i) (COCl)2, DMSO, Et3N, CH2Cl2,  
-78 oC; (ii) Allyl bromide, Zn, sat.NH4Cl, 0 oc, 82% over two steps; (f) PCC, CH3COONa, CH2Cl2, rt, 76%.
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The diol (7; Scheme 1) was synthesized from known epoxide 6 under 
regioselective reductive ring-opening reaction by Red-Al in THF at room temperature. 
Compound 7 was obtained in 92% yield. The primary alcohol of diol 7 was selectively 
protected with benzoyl group under BzCl/Et3N/CH2Cl2/0 oC condition and 
monoprotected compound 8 was obtained in 86% yield along with diprotected compound 
in 5% yield. The compound 8 was protected with tert-butyldimethylsilyl group under 
TBDMS-Cl/imidazole/CH2Cl2/rt and compound 9 was obtained in 90% yield. The 
benzoyl group was deprotected under basic conditions K2CO3/MeOH/rt to obtain the 
primary alcohol 10 in 89% yield. Alcohol 10 was oxidized under Swern conditions 
(COCl)2/DMSO/Et3N/CH2Cl2/-78 oC and the crude aldehyde was used in synthesis of 
homoallylic alcohol 11 under Barbier conditions (Zinc/allyl bromide/sat. NH4Cl) in THF 
and compound 11 obtained in 82% yield. Accordingly, the secondary alcohol 11 was 
oxidized with PCC/CH3COONa in CH2Cl2 at room temperature for 8 h to afford ketone 
12 in 76% yield.  
              
13
14
15
a b
c
12
Scheme 2
Reagents and condition: (a) HF.Pyridine, THF, rt, 63%; (b) Me4NBH(OAc)3, Acetic 
acid:Acetone (1:1), rt, 89%; (c) 2,2 DMP, CH2Cl2, 0 oC, 95%.
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MPMO
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To achieve stereoselective reduction of keto group, the hydroxy group should be 
unprotected and available for chelation. So, TBS group was deprotected using 
HF.Pyridine complex in THF at room temperature for 6 h at 0 oC to give 13 in 63% yield. 
D. A. Evans,74  had developed  tetramethylammonium triacetoxyborohydride 
(Me4NBH(OAc)3) for synthesis of 1,3-anti diols in acyclic compounds. Thus using the 
same conditions compound 14 was obtained (Scheme 2). The diastereomeric excess of 14 
(89%) thus obtained was assigned, as done earlier through the 13C NMR analysis of its 
acetonide 15.67            
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The terminal olefin 15 (Scheme 3) was subjected to reductive ozonolysis by 
passing ozone in CH2Cl2 at –78 oC for 30 min and then ozonide was cleaved with 
dimethylsulfide and stirred at room temperature for 12 h resulting in crude aldehyde, 
which was used as such without purification and characterization. Aldehyde was coupled 
with phenylacetylene under n-BuLi in THF at -78 oC to give separable products 16a and 
16b in ~ 1:1 ratio and in 88% yield.    
Product 16b was subjected to selective reduction with LiAlH4 in THF at 0 oC to 
give afford allylic alcohol 17 in 79% yield. Allylic alcohol was protected as its acetate 
under standard reaction conditions and 18 was obtained in 82% yield. Now, to obtain 
primary alcohol PMB group was deprotected with DDQ in CH2Cl2:H2O (19:1) at room 
temperature and primary alcohol 19 was obtained in 85% yield. The alcohol obtained was 
oxidized using 2-iodoxybenzoic acid (IBX) in dry DMSO at room temperature for 4 h to 
give aldehyde. The crude aldehyde was used as such without further purification and 
characterization. Thus adopting the reported reaction condition, the potassium salt of 
bis(2,2,2-trifluroethyl)(methoxycarbonyl methyl) phosphonate was reacted with the 
aldehyde under phase transfer conditions at –78 oC for 30 min. to afford the cis olefin 2 in 
81% yield along with some amount of trans-isomer 2a in 8% with Z/E ratio 9:1 (2/2a).75 
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Reagents and conditions: (a) (i) O3, DMS, CH2Cl2, -78 oC; (ii) Phenylacetylene, n-BuLi, THF, -78 oC, 88% 
over two steps (16a+16b); (b) LAH, THF, 0 oC, 79%; (c) Ac2O, Et3N, cat.DMAP, CH2Cl2, 0 oC, 82%; (d) 
DDQ, CH2Cl2:H2O (19:1), rt, 85%; (e) (i) IBX, DMSO, CH2Cl2, rt; (ii) (F3CCH2O)POCH2COOMe, KHMDS, 
18-crown-6, THF, -78 oC, 81% (Z), 8% (E).
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Reagents and conditions: (a)1N HCl, MeOH,  rt, 77%; (b) 3N HCl, MeOH, 60 oC
 
 
Olefine 2 (Scheme 4) was lactonized under 1N HCl in MeOH to give expected 
product 20 in 77% yield. Deprotection of acetate group in 20 was attempted under several 
reaction conditions but unfortunately the expected product was never obtained.76 This 
maybe attributed to the sensitive allylic acetate group. Our intension was to obtain the 
allylic alcohol 21 from 20, which could be chemoselectively oxidized under DDQ in 
CH2Cl2 at rt77 or MnO2 conditions to Kurzilactone 1. However, since the acetate 
deprotection proved difficult, the synthesis was stopped at this point and further work 
with compatible protecting groups is under progress in our laboratories. 
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